Mustang Bio, Inc. (NASDAQ:MBIO – Get Free Report) saw a large decrease in short interest in February. As of February 28th, there was short interest totalling 91,700 shares, a decrease of 22.4% from the February 13th total of 118,200 shares. Based on an average daily trading volume, of 310,600 shares, the days-to-cover ratio is presently 0.3 days. Currently, 6.4% of the shares of the company are sold short.
Mustang Bio Trading Down 0.8 %
Shares of MBIO stock traded down $0.01 during trading on Wednesday, reaching $1.42. 10,032 shares of the company’s stock traded hands, compared to its average volume of 242,565. The company has a market capitalization of $1.36 million, a P/E ratio of -0.02 and a beta of 1.82. The firm’s 50-day moving average is $3.85 and its 200 day moving average is $8.70. Mustang Bio has a 1 year low of $1.35 and a 1 year high of $67.00.
Institutional Trading of Mustang Bio
An institutional investor recently raised its position in Mustang Bio stock. Geode Capital Management LLC boosted its position in Mustang Bio, Inc. (NASDAQ:MBIO – Free Report) by 15.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 284,437 shares of the company’s stock after purchasing an additional 38,951 shares during the quarter. Geode Capital Management LLC owned about 29.63% of Mustang Bio worth $50,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 9.95% of the company’s stock.
Mustang Bio Company Profile
Mustang Bio, Inc, a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
See Also
- Five stocks we like better than Mustang Bio
- What is a Stock Market Index and How Do You Use Them?
- 3 Cash Cow Stocks Leading Their Sectors in Free Cash Flow Margins
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Retail Sales Data Signals a Surge: The E-Commerce Stock Picks
- Airline Stocks – Top Airline Stocks to Buy Now
- Qualcomm’s Low PE Ratio Makes It A Seriously Attractive Stock
Receive News & Ratings for Mustang Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mustang Bio and related companies with MarketBeat.com's FREE daily email newsletter.
